左心室辅助装置支持中的性别差异与结局:EUROMACS注册研究
基于EUROMACS注册966例患者(中位年龄55岁,女性151例)的多中心分析显示,女性在VAD植入时更常处于不稳定状态(INTERMACS 1-2级占51.7% vs 男性41.6%),且大出血、心律失常及右心衰竭需额外右心支持的发生率显著更高;女性孤立LVAD支持生存率显著更差(1年生存率75.5% vs 男性83.2%)。年龄校正Cox回归显示泵血栓与死亡率关联在女性中更强,肾功能不全与死亡率关联的性别方向不同(交互作用P值分别为0.028和0.023)。
要点
- 女性VAD植入时更常处于INTERMACS 1-2级不稳定状态,术后大出血、心律失常及右心衰竭发生率更高。
- 女性孤立LVAD支持1年生存率显著低于男性(75.5% vs 83.2%)。
- 泵血栓与死亡率关联在女性中更强,肾功能不全与死亡率关联的性别方向不同。
核心结论
- 男女在VAD植入后围术期血流动力学、不良事件及死亡率方面存在差异。
- 泵血栓与死亡率关联呈现性别依赖性,其对治疗实践的影响尚需进一步明确。
研究设计与样本
- 多中心注册数据分析,纳入EUROMACS注册966例患者(中位年龄55岁,女性151例),中位随访1.26年。
主要发现
- 女性VAD植入时INTERMACS 1-2级占比51.7%,男性为41.6%。
- 女性大出血(p=0.0012)、心律失常(p=0.022)及右心衰竭需额外右心支持(p<0.001)发生率显著高于男性。
- 女性孤立LVAD支持1年生存率75.5%,男性83.2%。
- 年龄校正Cox回归显示术前正性肌力治疗、经皮机械支持、INTERMACS 1-2级、右心功能障碍、大出血、脑出血、缺血性卒中及右心衰竭与死亡率显著相关。
- 泵血栓与死亡率关联在女性中更强(交互作用P=0.028),肾功能不全与死亡率关联方向男女不同(交互作用P=0.023)。
临床怎么用
- 临床应关注女性VAD患者术前不稳定状态及术后大出血、心律失常和右心衰竭风险。
- 对女性LVAD患者需警惕泵血栓对生存的更强负面影响,并注意肾功能与死亡率关联的性别差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the increasing use of ventricular assist devices (VADs), gender differences in indications, hemodynamics, and outcome are not well understood. We examined gender differences and gender-specific predictors for perioperative outcome in patients on ventricular support. METHODS: Multicenter data of 966 patients (median age 55 years, 151 women) from the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) were analyzed. Median follow-up was 1.26 years. RESULTS: At the time of VAD implantation, women were more often in an unstable condition (Interagency Registry for Mechanically Assisted Circulatory Support [INTERMACS] profile 1 and 2) (51.7% vs 41.6% in men), experiencing significantly more often major bleeding (p = 0.0012), arrhythmias (p = 0.022), and right ventricular (RV) failure (p < 0.001) with need for additional RV support. The survival of women on isolated LVAD support was significantly worse (1-year survival 75.5% vs 83.2% in men). Age-adjusted Cox regression analyses showed significant associations with mortality for preoperative inotropic therapy, percutaneous mechanical support, INTERMACS profile 1 and 2, RV dysfunction, major bleeding, cerebral bleeding, ischemic stroke, and RV failure. In women, pump thrombosis was more strongly related with mortality compared to men, while the direction of the association of renal dysfunction with mortality was different for women and men (p-value interaction 0.028 and 0.023, respectively). CONCLUSIONS: Women and men differ in perioperative hemodynamics, adverse events, and mortality after VAD implantation. A gender-dependent association of pump thrombosis with mortality was seen. The impact on treatment practice needs to be shown.
引用
- Magnussen C, Bernhardt AM, Ojeda FM, et al. Gender differences and outcomes in left ventricular assist device support: The European Registry for Patients with Mechanical Circulatory Support. J Heart Lung Transplant. 2017. PMID: 28754423. doi:10.1016/j.healun.2017.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。